Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaActive Not Recruiting
NCT03298451Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Brazil, Canada, China, France +12 more
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Recruiting
NCT07107945Phase 3Updated Jul 27, 2026
Sponsor: Boehringer Ingelheim
Chronic Kidney Disease
United States, Argentina, Australia, Belgium, Canada +13 more
SUPRATHEL 250 as a Treatment for Oropharyngeal WoundsRecruiting
NCT06543823NAUpdated Jul 27, 2026
Sponsor: Alaa Emara
Tonsillitis · Tonsillectomy · Tonsillitis Recurrent
Germany
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresRecruiting
NCT04715646Phase 3Updated Jul 27, 2026
Sponsor: UCB Biopharma SRL
Epilepsy
United States, Belgium, Czechia, France, Germany +6 more
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active Not Recruiting
NCT05269394Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +11 more
An Open-label Study of AZD0120 in Adults With Multiple SclerosisRecruiting
NCT07224373Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Multiple Sclerosis
United States, Australia, Canada, Germany, United Kingdom
A Study in Healthy People to Compare Two Tablet Formulations of PramipexoleNot Yet Recruiting
NCT07727785Phase 1Updated Jul 27, 2026
Sponsor: Boehringer Ingelheim
Healthy
Germany
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsRecruiting
NCT06772623Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: AbbVie
Non Small Cell Lung Carcinoma
United States, Belgium, China, France, Germany +9 more
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)Recruiting
NCT07489495Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Argentina, Australia, Brazil, Czechia +12 more
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruiting
NCT07064473Phase 3Updated Jul 27, 2026
Sponsor: Boehringer Ingelheim
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
United States, Argentina, Australia, Austria, Belgium +46 more
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting
NCT06841354Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive Not Recruiting
NCT05668013Phase 2Updated Jul 27, 2026
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Crohn Disease · Colitis, Ulcerative
United States, Austria, Bulgaria, Czechia, Georgia +11 more
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)Recruiting
NCT07227402Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Renal Cell Carcinoma
United States, Argentina, Australia, Austria, Belgium +17 more
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the AortaRecruiting
NCT07078383NAUpdated Jul 27, 2026
Sponsor: Vascutek Ltd.
Aortic Aneurysm · Aortic Aneurysm and Dissection · Aortic Diseases · Aneurysm of Aorta, Thoracic
United States, Austria, Germany, Netherlands, United Kingdom
Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).Recruiting
NCT07107022N/AUpdated Jul 27, 2026
Sponsor: Penumbra Inc.
Acute Ischemic Stroke (AIS)
Australia, France, Germany, Switzerland
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruiting
NCT07007312Phase 3Updated Jul 27, 2026
Sponsor: Kura Oncology, Inc.
Acute Myeloid Leukemia (AML)
United States, Australia, Belgium, Canada, Czechia +11 more
Tezspire Cardiac Events PASSRecruiting
NCT06951867N/AUpdated Jul 27, 2026
Sponsor: AstraZeneca
Cardiovascular Events · MACE
United States, Denmark, France, Germany
A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Ventricular ArrhythmiasRecruiting
NCT07727057NAUpdated Jul 27, 2026
Sponsor: Biosense Webster, Inc.
Arrhythmias, Cardiac
Austria, Belgium, France, Germany, Switzerland
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Recruiting
NCT06393374Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple-Negative Breast Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Recruiting
NCT07216703Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Cervical Cancer
United States, Argentina, Austria, Belgium, Brazil +22 more
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruiting
NCT07219173Phase 2Updated Jul 27, 2026
Sponsor: Eli Lilly and Company
Asthma
United States, Argentina, Brazil, Canada, China +7 more
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaRecruiting
NCT06158841Phase 3Updated Jul 27, 2026
Sponsor: AbbVie
Multiple Myeloma
United States, Australia, Austria, Belgium, Canada +20 more
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy ParticipantsCompleted
NCT07241065Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Healthy Participants
Germany
Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer PatientsNot Yet Recruiting
NCT06414122NAUpdated Jul 27, 2026
Sponsor: University of Cologne
Oesophageal Cancer · Gastric Cancer · Duodenal Cancer · Colorectal Cancer
Germany
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic ArthritisRecruiting
NCT04804553Phase 3Updated Jul 24, 2026
Sponsor: Amgen
Active Juvenile Psoriatic Arthritis
Austria, Belgium, France, Germany, Greece +10 more

Previous page Next page